Scherer R, Schmutzler M, Giebler R, Erhard J, Stöcker L, Kox W J
Institute of Anesthesiology, University Hospital of Essen, Federal Republic of Germany.
Acta Anaesthesiol Scand. 1993 May;37(4):370-4. doi: 10.1111/j.1399-6576.1993.tb03731.x.
In a prospective study, the complications of 1071 patients scheduled for thoracic epidural catheterization for postoperative analgesia (TEA) were studied. All catheters were inserted preoperatively between segment Th 2/3 and Th 11/12 under local anesthesia. Balanced anesthesia with endotracheal intubation and TEA were combined. Postoperatively 389 patients (36.9%) were monitored on a normal surgical ward. Buprenorphine, 0.15 to 0.3 mg, and if needed bupivacaine 0.375% 3-5 ml h-1 were given epidurally. Primary perforation of the dura occurred in 13 patients (1.23%). Radicular pain syndromes were observed in six patients (0.56%). In one patient (0.09%) respiratory depression was seen in close connection with the epidural administration of 0.3 mg buprenorphine. Although 116 patients (10.83%) showed one abnormal clotting parameter but no clinical signs of hemorrhage, there was no complication related to this group. No persisting neurological sequelae caused by the thoracic epidural catheters were found. In conclusion, continuous TEA with buprenorphine for postoperative pain relief after major abdominal surgery is a safe method without too high a risk of catheter-related or drug-induced complications, even on a normal surgical ward and when one clotting parameter is abnormal.
在一项前瞻性研究中,对1071例计划行胸段硬膜外导管置入用于术后镇痛(TEA)的患者的并发症进行了研究。所有导管均在术前于局部麻醉下在胸2/3至胸11/12节段之间插入。采用气管插管全身麻醉与TEA联合。术后389例患者(36.9%)在普通外科病房接受监测。硬膜外给予丁丙诺啡0.15至0.3mg,必要时给予0.375%布比卡因3 - 5ml/h。硬脊膜原发性穿孔发生在13例患者(1.23%)。6例患者(0.56%)观察到神经根疼痛综合征。1例患者(0.09%)在硬膜外给予0.3mg丁丙诺啡后出现呼吸抑制。虽然116例患者(10.83%)有一项凝血参数异常但无出血的临床体征,但该组未出现并发症。未发现胸段硬膜外导管引起的持续性神经后遗症。总之,对于腹部大手术后的术后疼痛缓解,持续使用丁丙诺啡进行TEA是一种安全的方法,即使在普通外科病房且一项凝血参数异常时,导管相关或药物引起的并发症风险也不高。